Evidence map›Paper›PMID 34158674›Full record

ArticleCanadian journal of chemistry2018

The Bioactive Lipid (S)-Sebastenoic Acid Impacts Motility and Dispersion in

Christopher J A Warner, Mauro Salinas, David Zamorano-Sánchez, Walter M Bray, R Scott Lokey, Fitnat H Yildiz, Roger G Linington

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian journal of chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 3 countries.

Christopher J A WarnerDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Mauro SalinasDepartment of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
David Zamorano-SánchezDepartment of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Walter M BrayChemical Screening Center, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
R Scott LokeyDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Fitnat H YildizDepartment of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
Roger G LiningtonDepartment of Chemistry and Biochemistry, University of California Santa Cruz, Santa Cruz, CA 95064, USA.
University of California, Santa Cruz · USSimon Fraser University · CA

Funding

Discovery and Development of Biofilm Inhibitors that Target c-di-GMP signalingR21AI098836 · NIAID · UNIVERSITY OF CALIFORNIA SANTA CRUZ · PI LININGTON, ROGER G · 2012 to 2013
$398k
NIAID NIH HHS R21 AI098836
6 · The paper itself

Abstract

Although Gram-negative bacterial pathogens continue to impart a substantial burden on global healthcare systems, much remains to be understood about aspects of basic physiology in these organisms. In recent years, cyclic-diguanylate (c-di-GMP) has emerged as a key regulator of a number of important processes related to pathogenicity, including biofilm formation, motility and virulence. In an effort to discover chemical genetic probes for studying

Indexed as

ActinobacteriaHigh-throughput screeningMotilityNatural productsVibrio cholerae

Identifiers

PMID34158674
PMCPMC8216231
OpenAlexW2767673540

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.